IP Library Granted Patent US 10,799,535
Granted Patent B2
US 10,799,535 · App. 15/766,290 · Granted Oct 13, 2020

Engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene

Inventors: Michael G. Nicholson (Chapel Hill, NC); James Jefferson Smith (Morrisville, NC); Derek Jantz (Durham, NC); Victor Bartsevich (Durham, NC); Daniel T. MacLeod (Durham, NC); Jeyaraj Antony (Chapel Hill, NC)
Assignee: Precision BioSciences, Inc.
A61K35/17A61K47/42A61K47/65A61K47/67A61P35/00C12N9/22A61K38/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,799,535
App. No.
15/766,290
Granted
Oct 13, 2020
Kind
B2
Abstract

Disclosed herein are recombinant meganucleases engineered to recognize and cleave a recognition sequence present in the human T cell receptor alpha constant region gene. The present disclosure further relates to the use of such recombinant meganucleases in methods for producing genetically-modified eukaryotic cells.

Claims (5)

1. An engineered meganuclease that binds and cleaves at a recognition sequence consisting of SEQ ID NO:3, wherein said engineered meganuclease comprises a first subunit and a second subunit, wherein said first subunit binds to a first recognition half-site of said recognition sequence, and wherein said second subunit binds to a second recognition half-site of said recognition sequence, and wherein said engineered meganuclease comprises an amino acid sequence having at least 96% identity to SEQ ID NO: 8.

2. The engineered meganuclease of claim 1 , wherein said first subunit comprises an amino acid sequence having at least 96% sequence identity to residues 198-344 of SEQ ID NO:8, and wherein said second subunit comprises an amino acid sequence having at least 96% sequence identity to residues 7-153 of SEQ ID NO:8.

3. The engineered meganuclease of claim 1 , wherein said first subunit comprises residues 198-344 of SEQ ID NO:8.

4. The engineered meganuclease of claim 1 , wherein said second subunit comprises residues 7-153 of SEQ ID NO:8.

5. The engineered meganuclease of claim 1 , wherein said engineered meganuclease comprises the amino acid sequence of SEQ ID NO:8.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 4, 2018
From: NICHOLSON, MICHAEL G.; SMITH, JAMES JEFFERSON; JANTZ, DEREK; BARTSEVICH, VICTOR; MACLEOD, DANIEL T.; ANTONY, JEYARAJ
To: PRECISION BIOSCIENCES, INC.
Reel/Frame 046778/0887 →
Continuity (3)
Provisional Application 62297445 · Feb 19, 2016
Provisional Application 62237382 · Oct 5, 2015
Related Publication 20180289741A1 · Oct 11, 2018
Cited By (1)
US 12,448,613